Share Price and Basic Stock Data
Last Updated: December 22, 2025, 9:50 pm
| PEG Ratio | 7.21 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mphasis Ltd, a prominent player in the IT consulting and software industry, has shown a steady trajectory in its revenue figures. The company reported sales of ₹13,798 Cr for the fiscal year ending March 2023, which marked a notable increase from ₹11,961 Cr in FY 2022. However, the latest quarterly figures indicate a slight decline in revenue, with sales dipping to ₹3,252 Cr in June 2023, before rebounding slightly to ₹3,276 Cr in September 2023. This fluctuation suggests that while Mphasis is resilient, it faces challenges in maintaining consistent growth amidst a dynamic market environment. The company’s revenue mix, heavily reliant on digital transformation and cloud services, positions it well against competitors, but it must navigate potential headwinds from macroeconomic factors and evolving client demands.
Profitability and Efficiency Metrics
Mphasis has demonstrated robust profitability metrics, with a reported operating profit margin (OPM) of 19% for the fiscal year ending March 2025, up from 18% in the previous fiscal year. This is indicative of the company’s ability to manage costs effectively while maximizing revenue. The net profit for FY 2025 stood at ₹1,739 Cr, translating to an earnings per share (EPS) of ₹89.87, reflecting a healthy growth trajectory from ₹82.42 in FY 2024. The company’s return on equity (ROE) is an impressive 18.2%, which is above industry averages, showcasing its efficiency in utilizing shareholders’ equity to generate profits. However, a closer examination of its cash conversion cycle, which extended to 73 days, raises some concerns about operational efficiency, indicating that the company may need to enhance its working capital management to optimize cash flows.
Balance Sheet Strength and Financial Ratios
The financial health of Mphasis appears solid, with a market capitalization of ₹55,190 Cr and a low debt-to-equity ratio of 0.11, suggesting that the company maintains a conservative approach to leverage. The borrowings reported at ₹1,979 Cr are manageable against total reserves of ₹9,432 Cr, providing a cushion for future investments and operational needs. Furthermore, the interest coverage ratio stands at a robust 17.53x, indicating that the company comfortably covers its interest obligations. However, the price-to-book value ratio of 4.94x may suggest that the stock is trading at a premium compared to its book value, which could deter value-focused investors. In the broader context, Mphasis’s financial ratios reflect a company that is not only growing but doing so in a financially prudent manner, although the elevated P/BV might warrant caution.
Shareholding Pattern and Investor Confidence
Mphasis’s shareholding structure reveals a diverse investor base, with promoters holding 40.10% of the equity. This is a significant drop from previous levels, indicating that there may have been some dilution or strategic selling. Foreign institutional investors (FIIs) currently hold 18.52%, while domestic institutional investors (DIIs) have increased their stake to 37.08%, signaling confidence in the company’s long-term prospects. The public shareholding is relatively small at 4.31%, which could limit liquidity but also indicates concentrated institutional support. The fluctuation in promoter holdings, alongside a stable DII presence, reflects an evolving investor sentiment, which could influence stock volatility. A healthy balance between institutional and retail investors can bolster market confidence, but the declining promoter stake may raise questions about future strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Mphasis is poised for continued growth, driven by its strong positioning in digital transformation and cloud computing. However, it must contend with risks such as fluctuating demand from its client base and potential geopolitical uncertainties that could impact global IT spending. The tightening macroeconomic conditions may also pose challenges to its revenue growth. Investors should remain vigilant about operational efficiencies, particularly in managing the cash conversion cycle, as any delays in receivables could strain liquidity. In sum, while Mphasis presents a compelling investment story supported by strong financials, the evolving market dynamics and shifts in shareholder structure warrant careful consideration. Investors might view this stock as a long-term play, keeping an eye on key operational metrics and market conditions that could influence its trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 119 Cr. | 73.4 | 101/17.6 | 58.5 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 12.0 Cr. | 41.5 | 64.9/33.1 | 8.14 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 24.8 Cr. | 72.0 | 170/67.0 | 16.8 | 15.0 | 1.39 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 128,095.06 Cr | 846.04 | 47.78 | 158.22 | 0.76% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,411 | 3,520 | 3,506 | 3,361 | 3,252 | 3,276 | 3,338 | 3,412 | 3,422 | 3,536 | 3,561 | 3,710 | 3,732 |
| Expenses | 2,811 | 2,902 | 2,889 | 2,763 | 2,665 | 2,681 | 2,737 | 2,773 | 2,804 | 2,888 | 2,883 | 3,007 | 3,030 |
| Operating Profit | 600 | 618 | 618 | 599 | 587 | 596 | 601 | 639 | 619 | 648 | 678 | 703 | 703 |
| OPM % | 18% | 18% | 18% | 18% | 18% | 18% | 18% | 19% | 18% | 18% | 19% | 19% | 19% |
| Other Income | 36 | 43 | 40 | 43 | 50 | 49 | 54 | 64 | 74 | 59 | 63 | 60 | 81 |
| Interest | 23 | 26 | 24 | 24 | 24 | 34 | 53 | 50 | 50 | 40 | 39 | 36 | 42 |
| Depreciation | 80 | 80 | 82 | 83 | 87 | 89 | 103 | 131 | 105 | 104 | 132 | 135 | 132 |
| Profit before tax | 533 | 555 | 551 | 534 | 526 | 522 | 499 | 522 | 537 | 563 | 569 | 591 | 610 |
| Tax % | 25% | 25% | 25% | 24% | 25% | 25% | 25% | 25% | 25% | 25% | 25% | 24% | 28% |
| Net Profit | 402 | 418 | 412 | 405 | 396 | 392 | 374 | 393 | 405 | 423 | 428 | 446 | 442 |
| EPS in Rs | 21.37 | 22.24 | 21.89 | 21.51 | 21.01 | 20.78 | 19.79 | 20.81 | 21.39 | 22.37 | 22.56 | 23.49 | 23.22 |
Last Updated: August 1, 2025, 4:50 pm
Below is a detailed analysis of the quarterly data for Mphasis Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,732.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,710.00 Cr. (Mar 2025) to 3,732.00 Cr., marking an increase of 22.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,030.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,007.00 Cr. (Mar 2025) to 3,030.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 703.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 703.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
- For Other Income, as of Jun 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Mar 2025) to 81.00 Cr., marking an increase of 21.00 Cr..
- For Interest, as of Jun 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 135.00 Cr. (Mar 2025) to 132.00 Cr., marking a decrease of 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 610.00 Cr.. The value appears strong and on an upward trend. It has increased from 591.00 Cr. (Mar 2025) to 610.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 28.00%, marking an increase of 4.00%.
- For Net Profit, as of Jun 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 446.00 Cr. (Mar 2025) to 442.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.22. The value appears to be declining and may need further review. It has decreased from 23.49 (Mar 2025) to 23.22, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:57 am
| Metric | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,594 | 5,795 | 6,081 | 6,076 | 6,546 | 7,731 | 8,844 | 9,722 | 11,961 | 13,798 | 13,279 | 14,230 | 14,906 |
| Expenses | 2,154 | 4,925 | 5,218 | 5,108 | 5,483 | 6,407 | 7,193 | 7,919 | 9,844 | 11,365 | 10,857 | 11,583 | 12,101 |
| Operating Profit | 440 | 870 | 863 | 969 | 1,062 | 1,324 | 1,650 | 1,803 | 2,118 | 2,434 | 2,422 | 2,647 | 2,805 |
| OPM % | 17% | 15% | 14% | 16% | 16% | 17% | 19% | 19% | 18% | 18% | 18% | 19% | 19% |
| Other Income | 44 | 194 | 172 | 223 | 149 | 177 | 178 | 133 | 160 | 162 | 218 | 255 | 278 |
| Interest | 11 | 28 | 24 | 14 | 13 | 17 | 81 | 63 | 74 | 97 | 161 | 166 | 161 |
| Depreciation | 50 | 98 | 121 | 79 | 71 | 76 | 232 | 242 | 291 | 325 | 410 | 476 | 527 |
| Profit before tax | 422 | 938 | 890 | 1,099 | 1,128 | 1,407 | 1,515 | 1,631 | 1,913 | 2,173 | 2,068 | 2,260 | 2,395 |
| Tax % | 28% | 28% | 29% | 28% | 26% | 24% | 22% | 25% | 25% | 25% | 25% | 25% | |
| Net Profit | 303 | 675 | 632 | 792 | 838 | 1,073 | 1,185 | 1,217 | 1,431 | 1,638 | 1,555 | 1,702 | 1,785 |
| EPS in Rs | 14.40 | 32.10 | 30.05 | 37.62 | 43.34 | 57.64 | 63.52 | 65.06 | 76.19 | 86.94 | 82.27 | 89.55 | 93.92 |
| Dividend Payout % | 49% | 50% | 67% | 45% | 46% | 47% | 55% | 100% | 60% | 58% | 67% | 64% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.37% | 25.32% | 5.81% | 28.04% | 10.44% | 2.70% | 17.58% | 14.47% | -5.07% | 9.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 31.69% | -19.51% | 22.23% | -17.60% | -7.74% | 14.88% | -3.12% | -19.53% | 14.52% |
Mphasis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 20% |
| 3 Years: | 12% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 19% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 11:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 210 | 210 | 210 | 210 | 193 | 186 | 187 | 187 | 188 | 188 | 189 | 190 | 190 |
| Reserves | 4,905 | 5,270 | 5,645 | 5,942 | 5,289 | 5,064 | 5,643 | 6,340 | 6,755 | 7,746 | 8,606 | 9,438 | 9,432 |
| Borrowings | 540 | 575 | 461 | 260 | 390 | 543 | 571 | 513 | 527 | 198 | 1,544 | 1,116 | 1,979 |
| Other Liabilities | 1,320 | 1,312 | 1,092 | 889 | 1,109 | 1,576 | 2,339 | 2,324 | 3,214 | 3,373 | 3,662 | 4,000 | 4,672 |
| Total Liabilities | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
| Fixed Assets | 2,404 | 2,334 | 1,597 | 1,921 | 1,884 | 2,170 | 3,013 | 3,020 | 3,774 | 4,060 | 5,533 | 5,781 | 6,091 |
| CWIP | 6 | 20 | 56 | 1 | 2 | 3 | 17 | 3 | 11 | 32 | 61 | 0 | 1 |
| Investments | 1,815 | 1,443 | 2,122 | 2,396 | 1,782 | 1,329 | 1,326 | 1,846 | 1,813 | 1,753 | 3,090 | 2,208 | 1,464 |
| Other Assets | 2,748 | 3,569 | 3,633 | 2,983 | 3,312 | 3,866 | 4,384 | 4,496 | 5,087 | 5,662 | 5,316 | 6,754 | 8,718 |
| Total Assets | 6,974 | 7,367 | 7,408 | 7,301 | 6,980 | 7,368 | 8,740 | 9,365 | 10,684 | 11,506 | 14,000 | 14,744 | 16,273 |
Below is a detailed analysis of the balance sheet data for Mphasis Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 190.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 190.00 Cr..
- For Reserves, as of Sep 2025, the value is 9,432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,438.00 Cr. (Mar 2025) to 9,432.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,979.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,116.00 Cr. (Mar 2025) to 1,979.00 Cr., marking an increase of 863.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,672.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,000.00 Cr. (Mar 2025) to 4,672.00 Cr., marking an increase of 672.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 16,273.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6,091.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,781.00 Cr. (Mar 2025) to 6,091.00 Cr., marking an increase of 310.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 1,464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,208.00 Cr. (Mar 2025) to 1,464.00 Cr., marking a decrease of 744.00 Cr..
- For Other Assets, as of Sep 2025, the value is 8,718.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,754.00 Cr. (Mar 2025) to 8,718.00 Cr., marking an increase of 1,964.00 Cr..
- For Total Assets, as of Sep 2025, the value is 16,273.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,744.00 Cr. (Mar 2025) to 16,273.00 Cr., marking an increase of 1,529.00 Cr..
Notably, the Reserves (9,432.00 Cr.) exceed the Borrowings (1,979.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014n n 5m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 440.00 | 295.00 | 402.00 | 709.00 | -389.00 | -542.00 | -570.00 | -512.00 | -525.00 | -196.00 | 1.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 109 | 39 | 39 | 38 | 45 | 45 | 34 | 35 | 68 | 67 | 67 | 73 |
| Working Capital Days | 22 | -5 | 20 | 29 | 21 | 19 | 6 | 15 | 13 | 19 | -27 | -22 |
| ROCE % | 16% | 15% | 18% | 19% | 24% | 26% | 25% | 27% | 29% | 24% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 7,771,095 | 3.61 | 2184.77 | 6,593,880 | 2025-12-15 04:18:40 | 17.85% |
| HDFC Mid Cap Fund | 4,433,657 | 1.35 | 1246.48 | 4,182,210 | 2025-12-15 04:18:40 | 6.01% |
| ICICI Prudential Technology Fund | 2,336,725 | 4.22 | 656.95 | 2,264,203 | 2025-12-15 04:18:40 | 3.2% |
| Kotak Large & Midcap Fund | 2,200,000 | 2.06 | 618.51 | N/A | N/A | N/A |
| Kotak Multicap Fund | 1,652,887 | 2.09 | 464.69 | 1,702,887 | 2025-12-15 04:18:40 | -2.94% |
| ICICI Prudential Focused Equity Fund | 1,553,625 | 3.09 | 436.79 | N/A | N/A | N/A |
| HDFC Large and Mid Cap Fund | 1,537,999 | 1.5 | 432.39 | N/A | N/A | N/A |
| HDFC Balanced Advantage Fund | 1,257,231 | 0.33 | 353.46 | N/A | N/A | N/A |
| DSP Mid Cap Fund | 1,246,962 | 1.77 | 350.57 | N/A | N/A | N/A |
| Kotak Balanced Advantage Fund | 1,155,896 | 1.81 | 324.97 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 89.87 | 82.42 | 87.05 | 76.38 | 65.18 |
| Diluted EPS (Rs.) | 89.36 | 81.83 | 86.37 | 75.61 | 64.43 |
| Cash EPS (Rs.) | 114.61 | 103.98 | 104.20 | 91.66 | 77.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 506.53 | 465.31 | 421.15 | 369.66 | 348.93 |
| Revenue From Operations / Share (Rs.) | 748.62 | 702.55 | 732.38 | 636.84 | 519.77 |
| PBDIT / Share (Rs.) | 152.67 | 139.66 | 137.76 | 121.29 | 103.49 |
| PBIT / Share (Rs.) | 127.61 | 117.94 | 120.50 | 105.81 | 90.56 |
| PBT / Share (Rs.) | 118.90 | 109.43 | 115.34 | 101.84 | 87.17 |
| Net Profit / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| NP After MI And SOA / Share (Rs.) | 89.55 | 82.26 | 86.94 | 76.18 | 65.05 |
| PBDIT Margin (%) | 20.39 | 19.87 | 18.81 | 19.04 | 19.91 |
| PBIT Margin (%) | 17.04 | 16.78 | 16.45 | 16.61 | 17.42 |
| PBT Margin (%) | 15.88 | 15.57 | 15.74 | 15.99 | 16.77 |
| Net Profit Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| NP After MI And SOA Margin (%) | 11.96 | 11.70 | 11.87 | 11.96 | 12.51 |
| Return on Networth / Equity (%) | 17.67 | 17.67 | 20.64 | 20.60 | 18.64 |
| Return on Capital Employeed (%) | 23.19 | 22.45 | 25.76 | 25.32 | 23.34 |
| Return On Assets (%) | 11.41 | 11.00 | 14.10 | 13.30 | 12.94 |
| Total Debt / Equity (X) | 0.11 | 0.17 | 0.02 | 0.07 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.03 | 1.05 | 0.90 | 0.75 |
| Current Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Quick Ratio (X) | 1.57 | 1.58 | 2.13 | 1.96 | 2.40 |
| Dividend Payout Ratio (NP) (%) | 61.10 | 60.64 | 52.82 | 85.08 | 53.66 |
| Dividend Payout Ratio (CP) (%) | 47.74 | 47.97 | 44.07 | 70.71 | 44.76 |
| Earning Retention Ratio (%) | 38.90 | 39.36 | 47.18 | 14.92 | 46.34 |
| Cash Earning Retention Ratio (%) | 52.26 | 52.03 | 55.93 | 29.29 | 55.24 |
| Interest Coverage Ratio (X) | 17.53 | 16.41 | 26.69 | 30.62 | 30.53 |
| Interest Coverage Ratio (Post Tax) (X) | 11.28 | 10.67 | 17.84 | 20.23 | 20.19 |
| Enterprise Value (Cr.) | 47038.62 | 45867.38 | 32991.41 | 62998.79 | 32810.46 |
| EV / Net Operating Revenue (X) | 3.31 | 3.45 | 2.39 | 5.27 | 3.37 |
| EV / EBITDA (X) | 16.21 | 17.38 | 12.71 | 27.65 | 16.95 |
| MarketCap / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| Retention Ratios (%) | 38.89 | 39.35 | 47.17 | 14.91 | 46.33 |
| Price / BV (X) | 4.94 | 5.13 | 4.27 | 9.13 | 5.11 |
| Price / Net Operating Revenue (X) | 3.34 | 3.40 | 2.45 | 5.30 | 3.43 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Mphasis Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 89.87. This value is within the healthy range. It has increased from 82.42 (Mar 24) to 89.87, marking an increase of 7.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 89.36. This value is within the healthy range. It has increased from 81.83 (Mar 24) to 89.36, marking an increase of 7.53.
- For Cash EPS (Rs.), as of Mar 25, the value is 114.61. This value is within the healthy range. It has increased from 103.98 (Mar 24) to 114.61, marking an increase of 10.63.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 506.53. It has increased from 465.31 (Mar 24) to 506.53, marking an increase of 41.22.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 748.62. It has increased from 702.55 (Mar 24) to 748.62, marking an increase of 46.07.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 152.67. This value is within the healthy range. It has increased from 139.66 (Mar 24) to 152.67, marking an increase of 13.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 127.61. This value is within the healthy range. It has increased from 117.94 (Mar 24) to 127.61, marking an increase of 9.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 118.90. This value is within the healthy range. It has increased from 109.43 (Mar 24) to 118.90, marking an increase of 9.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 89.55. This value is within the healthy range. It has increased from 82.26 (Mar 24) to 89.55, marking an increase of 7.29.
- For PBDIT Margin (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 20.39, marking an increase of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 17.04. This value is within the healthy range. It has increased from 16.78 (Mar 24) to 17.04, marking an increase of 0.26.
- For PBT Margin (%), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 15.57 (Mar 24) to 15.88, marking an increase of 0.31.
- For Net Profit Margin (%), as of Mar 25, the value is 11.96. This value exceeds the healthy maximum of 10. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.96. This value is within the healthy range. It has increased from 11.70 (Mar 24) to 11.96, marking an increase of 0.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.67. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 17.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.19. This value is within the healthy range. It has increased from 22.45 (Mar 24) to 23.19, marking an increase of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.41, marking an increase of 0.41.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.17 (Mar 24) to 0.11, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.03 (Mar 24) to 0.98, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.57, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 61.10. This value exceeds the healthy maximum of 50. It has increased from 60.64 (Mar 24) to 61.10, marking an increase of 0.46.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 47.74. This value is within the healthy range. It has decreased from 47.97 (Mar 24) to 47.74, marking a decrease of 0.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 38.90. This value is below the healthy minimum of 40. It has decreased from 39.36 (Mar 24) to 38.90, marking a decrease of 0.46.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 52.26. This value is within the healthy range. It has increased from 52.03 (Mar 24) to 52.26, marking an increase of 0.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.53. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.53, marking an increase of 1.12.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 10.67 (Mar 24) to 11.28, marking an increase of 0.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 47,038.62. It has increased from 45,867.38 (Mar 24) to 47,038.62, marking an increase of 1,171.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 3.45 (Mar 24) to 3.31, marking a decrease of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 16.21. This value exceeds the healthy maximum of 15. It has decreased from 17.38 (Mar 24) to 16.21, marking a decrease of 1.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For Retention Ratios (%), as of Mar 25, the value is 38.89. This value is within the healthy range. It has decreased from 39.35 (Mar 24) to 38.89, marking a decrease of 0.46.
- For Price / BV (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 5.13 (Mar 24) to 4.94, marking a decrease of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 3.40 (Mar 24) to 3.34, marking a decrease of 0.06.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mphasis Ltd:
- Net Profit Margin: 11.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.19% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.67% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.28
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.8 (Industry average Stock P/E: 47.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Bagmane World Technology Center, Bengaluru Karnataka 560048 | investor.relations@mphasis.com http://www.mphasis.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Jan Kathleen Hier | Chairman |
| Mr. Nitin Rakesh | Managing Director & CEO |
| Mr. Marshall Jan Lux | Non Executive Director |
| Mr. Amit Dalmia | Non Executive Director |
| Mr. Amit Dixit | Non Executive Director |
| Mr. David Lawrence Johnson | Non Executive Director |
| Ms. Courtney Della Cava | Non Executive Director |
| Mr. Kabir Mathur | Non Executive Director |
| Mr. Pankaj Sood | Non Executive Director |
| Mr. Girish Paranjpe | Independent Director |
| Ms. Maureen Anne Erasmus | Independent Director |
| Mr. Sunil Gulati | Independent Director |
FAQ
What is the intrinsic value of Mphasis Ltd?
Mphasis Ltd's intrinsic value (as of 22 December 2025) is 2313.85 which is 19.85% lower the current market price of 2,887.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 54,987 Cr. market cap, FY2025-2026 high/low of 3,078/2,025, reserves of ₹9,432 Cr, and liabilities of 16,273 Cr.
What is the Market Cap of Mphasis Ltd?
The Market Cap of Mphasis Ltd is 54,987 Cr..
What is the current Stock Price of Mphasis Ltd as on 22 December 2025?
The current stock price of Mphasis Ltd as on 22 December 2025 is 2,887.
What is the High / Low of Mphasis Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mphasis Ltd stocks is 3,078/2,025.
What is the Stock P/E of Mphasis Ltd?
The Stock P/E of Mphasis Ltd is 30.8.
What is the Book Value of Mphasis Ltd?
The Book Value of Mphasis Ltd is 506.
What is the Dividend Yield of Mphasis Ltd?
The Dividend Yield of Mphasis Ltd is 1.97 %.
What is the ROCE of Mphasis Ltd?
The ROCE of Mphasis Ltd is 22.7 %.
What is the ROE of Mphasis Ltd?
The ROE of Mphasis Ltd is 18.2 %.
What is the Face Value of Mphasis Ltd?
The Face Value of Mphasis Ltd is 10.0.